Ken Fisher's AMGN Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 903,557 shares of Amgen Inc. (AMGN) worth $295.74 M, representing 0.10% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 375,463 shares. Largest reduction occurred in Q4 2019, reducing 52,321 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +118,273 | Add 15.06% | 903,557 | $327.31 |
| Q3 2025 | +375,463 | Add 91.62% | 785,284 | $282.20 |
| Q2 2025 | -28,003 | Reduce 6.40% | 409,821 | $279.21 |
| Q1 2025 | +43,335 | Add 10.99% | 437,824 | $311.55 |
| Q4 2024 | +292,137 | Add 285.42% | 394,489 | $260.64 |
| Q3 2024 | +17,974 | Add 21.30% | 102,352 | $322.21 |
| Q2 2024 | +6,822 | Add 8.80% | 84,378 | $312.45 |
| Q1 2024 | -1,197 | Reduce 1.52% | 77,556 | $284.32 |
| Q4 2023 | +3,049 | Add 4.03% | 78,753 | $288.02 |
| Q3 2023 | -8,123 | Reduce 9.69% | 75,704 | $268.76 |
| Q2 2023 | +3,774 | Add 4.71% | 83,827 | $222.02 |
| Q1 2023 | +716 | Add 0.90% | 80,053 | $241.75 |
| Q4 2022 | +1,657 | Add 2.13% | 79,337 | $262.64 |
| Q3 2022 | -292 | Reduce 0.37% | 77,680 | $225.40 |
| Q2 2022 | +1,358 | Add 1.77% | 77,972 | $243.31 |
| Q1 2022 | -2,406 | Reduce 3.04% | 76,614 | $241.82 |
| Q4 2021 | +3,509 | Add 4.65% | 79,020 | $224.97 |
| Q3 2021 | -2,413 | Reduce 3.10% | 75,511 | $212.66 |
| Q2 2021 | +5,106 | Add 7.01% | 77,924 | $243.75 |
| Q1 2021 | +403 | Add 0.56% | 72,818 | $248.81 |
| Q4 2020 | +730 | Add 1.02% | 72,415 | $229.92 |
| Q3 2020 | +3,343 | Add 4.89% | 71,685 | $254.15 |
| Q2 2020 | +358 | Add 0.53% | 68,342 | $235.86 |
| Q1 2020 | -46,782 | Reduce 40.76% | 67,984 | $202.74 |
| Q4 2019 | -52,321 | Reduce 31.31% | 114,766 | $241.07 |
| Q3 2019 | +3,494 | Add 2.14% | 167,087 | $193.51 |
| Q2 2019 | +4,128 | Add 2.59% | 163,593 | $184.28 |
| Q1 2019 | +7,033 | Add 4.61% | 159,465 | $189.98 |
| Q4 2018 | +2,600 | Add 1.74% | 152,432 | $194.67 |
| Q3 2018 | +826 | Add 0.55% | 149,832 | $207.29 |
| Q2 2018 | +2,942 | Add 2.01% | 149,006 | $184.59 |
| Q1 2018 | +33,977 | Add 30.31% | 146,064 | $170.48 |
| Q4 2017 | -17,305 | Reduce 13.37% | 112,087 | $173.90 |
| Q3 2017 | +2,855 | Add 2.26% | 129,392 | $186.45 |
| Q2 2017 | +3,517 | Add 2.86% | 126,537 | $172.23 |
| Q1 2017 | -119 | Reduce 0.10% | 123,020 | $164.07 |
| Q4 2016 | +20,345 | Add 19.79% | 123,139 | $146.21 |
| Q3 2016 | +1,221 | Add 1.20% | 102,794 | $166.81 |
| Q2 2016 | -11,120 | Reduce 9.87% | 101,573 | $160.18 |
| Q1 2016 | -23,707 | Reduce 17.38% | 112,693 | $160.13 |
| Q4 2015 | +2,768 | Add 2.07% | 136,400 | $162.33 |
| Q3 2015 | -21,469 | Reduce 13.84% | 133,632 | $138.32 |
| Q2 2015 | -1,522 | Reduce 0.97% | 155,101 | $153.52 |
| Q1 2015 | +2,184 | Add 1.41% | 156,623 | $159.85 |
| Q4 2014 | -2,190 | Reduce 1.40% | 154,439 | $159.29 |
| Q3 2014 | +71,313 | Add 83.59% | 156,629 | $140.46 |
| Q2 2014 | +35,429 | Add 71.02% | 85,316 | $118.37 |
| Q1 2014 | +44,050 | Add 754.67% | 49,887 | $123.34 |
| Q4 2013 | +205 | Add 3.64% | 5,837 | $114.10 |
| Q3 2013 | -781 | Reduce 12.18% | 5,632 | $111.86 |
| Q2 2013 | +6,413 | Add 0.00% | 6,413 | $98.71 |
Ken Fisher's Amgen Investment FAQs
Ken Fisher first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 6,413 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Amgen Inc. (AMGN) for 51 quarters since Q2 2013.
Ken Fisher's largest addition to Amgen Inc. (AMGN) was in Q3 2025, adding 785,284 shares worth $221.61 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 903,557 shares of Amgen Inc. (AMGN), valued at approximately $295.74 M.
As of the Q4 2025 filing, Amgen Inc. (AMGN) represents approximately 0.10% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Amgen Inc. (AMGN) was 903,557 shares, as reported at the end of Q4 2025.